Skip to main content
MIT/Mayo Physical Sciences Center for Drug Distribution and Drug Efficacy in Brain Tumors
Home
About
Research
Investigators
Publications
News & Events
Seminar Videos
Contact
Publications
Found 1 results
Filters:
Keyword
is
Antimitotic Agents
[Clear All Filters]
2022
Kenchappa RS, Dovas A, Argenziano MG, Meyer CT, Stopfer LE, Banu MA, Pereira B, Griffith J, Mohammad A, Talele S et al.
. 2022.
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
.
Cell Rep. 39(12):110991.
News & Events
MIT PS-OC Mini-Symposium
May 30, 2017
Ludwig Center Oncology Seminar
May 8, 2017
Recent Publications
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma.
De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma.
Spatially resolved characterization of tissue metabolic compartments in fasted and high-fat diet livers.
Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma.
More...